Access to medicine transforms lives. Join us on a mission to reach 8 billion. | Access to Medicine

ACCESS TO MEDICINE INDEX 2022

AMR Programme

Learn more about our work on antimicrobial resistance

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

What steps are companies taking to help curb AMR by manufacturing responsibly?

Briefing for High-Level Meeting on AMR at UN General Assembly 2024

What the High-level meeting should prioritise when engaging the pharmaceutical industry on combatting antimicrobial resistance

Explore per sector

R&D-based pharma companies

We encourage them to make their products accessible.

Generic medicine manufacturers

We empower the industry to become more responsive.

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Vaccine manufacturers

We guide them to improve access to immunisation.

Resource centre

Explore our research reports and publications

2024 Amsterdam Session on Diabetes Care - Meeting Report

There are far too many avoidable deaths in childbirth

18 January 2024

Investor launch event for new analysis of major generics companies – Meeting Report

31 October 2023

Diabetes Care Programme

By assessing current industry practice and engaging key players to do more, we aim to drive improvements in access to diabetes care worldwide.

Events and engagements

SHARING OUR INSIGHTS TO HELP DRIVE CHANGE

PRI Conference 2024: Suzi van Es to share insights from upcoming Index with investor attendees

08 October 2024

Panel discussion

Jayasree K. Iyer returns to annual World Health Summit to discuss gaps in access to medical oxygen and other priority global health issues

15 October 2024

International Society for Pediatric and Adolescent Diabetes 50th Annual Congress - Lisbon, Portugal

16 October 2024

Featured Panel discussion

Martijn van Gerven joins keynote panel at World AMR Congress 2024

06 September 2024

Media coverage

Read more about our coverage in global media

Pharma must ramp up access, stewardship efforts in AMR research, new report finds

Combating superbugs: How Indian drugmakers can address the global shortfall in antibiotic development